Literature DB >> 15484322

Possible stem cell origin of human cholangiocarcinoma.

Chao Liu1, Jie Wang, Qing-Jia Ou.   

Abstract

AIM: To investigate the expression of CD34 and c-kit (receptor of stem cell factor) in cholangiocarcinoma.
METHODS: Fifteen cases of intrahepatic cholangiocarcinoma and 17 cases of extrahepatic cholangiocarcinoma were studied in this experiment. Using Envision detection system, paraffin-embedded sections of the resected cholangiocarcinoma tissue were stained with antibodies against CD34 and c-kit, respectively. The sections were counterstained with hematoxylin, and the results were examined under light microscope. Normal tonsil and mammary tissues were used as positive controls for CD34 and c-kit, respectively.
RESULTS: CD34 was positive in all sections, but only in capillary endothelial cells of tumor tissue. No cholangiocarcinoma cells were positive for CD34. In one case of extrahepatic cholangiocarcinoma, a few tumor cells (about 5%) were immunoreactive with c-kit.
CONCLUSION: CD34 or c-kit positive cells in liver tissue may represent liver stem cells, as they can differentiate into mature biliary cells in vitro. The expression of c-kit by some cholangiocarcinoma cells suggests that cholangiocarcinoma might originate from liver stem cells. However, other mechanisms of hepatocarcinogenesis, such as de-differentiation of mature cholangiocytes, may also exist.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15484322      PMCID: PMC4572317          DOI: 10.3748/wjg.v10.i22.3374

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

Review 1.  The liver as a stem cell and lineage system.

Authors:  S H Sigal; S Brill; A S Fiorino; L M Reid
Journal:  Am J Physiol       Date:  1992-08

Review 2.  Hepatic stem cells.

Authors:  M Alison; C Sarraf
Journal:  J Hepatol       Date:  1998-10       Impact factor: 25.083

3.  Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium.

Authors:  H A Crosby; D A Kelly; A J Strain
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

4.  Heterogeneity of the "oval-cell" response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment.

Authors:  J H Lee; H J Rim; S Sell
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

Review 5.  Hepatic stem cells.

Authors:  S S Thorgeirsson
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

Review 6.  Hepatic stem cells: existence and origin.

Authors:  Ying Zhang; Xue-Fan Bai; Chang-Xing Huang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

7.  Hepatocellular carcinoma presenting as a tumour of the hilar and extrahepatic bile ducts.

Authors:  G H Thomsen; A Kruse; A Petersen
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-09       Impact factor: 2.566

8.  Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6.

Authors:  P Ruck; J C Xiao; T Pietsch; D Von Schweinitz; E Kaiserling
Journal:  Histopathology       Date:  1997-10       Impact factor: 5.087

9.  Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man.

Authors:  T Roskams; R De Vos; P Van Eyken; H Myazaki; B Van Damme; V Desmet
Journal:  J Hepatol       Date:  1998-09       Impact factor: 25.083

10.  Extrahepatic bile duct hepatocellular carcinoma without primary hepatic parenchymal lesions--a case report.

Authors:  H G Cho; J P Chung; K S Lee; C Y Chon; J K Kang; I S Park; K W Kim; H S Chi; H Kim
Journal:  Korean J Intern Med       Date:  1996-06       Impact factor: 2.884

View more
  2 in total

1.  Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma.

Authors:  Yong-Jun Chen; Qi-Bin Tang; Shen-Quan Zou
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

Review 2.  C-Kit, a Double-Edged Sword in Liver Regeneration and Diseases.

Authors:  Weina Wang; Liyan Shui; Yanning Liu; Min Zheng
Journal:  Front Genet       Date:  2021-02-02       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.